Biotech Values

[dewophile]

And to be clear GSKs maternal RSV program was not using adjuvant so very similar to what PFE has in the clinic.
Will be a nice win though if they cross the finish line. Gsk incidentally just got approval for their DPT vaccine to be used for vertical immunity in pregnancy for whooping cough. I can see pregnant women wanting to minimize any and all exposures so not sure the commercial opportunity